EPIGENETIC REGULATION OF FRA2 BY JMJD3 REGULATES FIBROBLAST ACTIVATION IN SYSTEMIC SCLEROSIS

Bergmann C, Brandt A, Dees C, Wohlfahrt T, Zhang Y, Chen CW, Mallano T, Liang R, Kagwiria R, Kam PS, Bozec A, Abraham D, Rieker R, Ramming A, Distler O, Schett G, Distler J (2017)

Publication Type: Conference contribution

Publication year: 2017

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Book Volume: 76

Pages Range: 892-893

Authors with CRIS profile

Adrian Brandt Lehrstuhl für Arbeits-, Sozial- und Umweltmedizin Clara Dees Department of Medicine 3 – Rheumatology and Immunology Ruifang Liang Professur für Molekulare und Experimentelle Chirurgie Aline Bozec Juniorprofessur für Osteoimmunologie Ralf Rieker Institute of Pathology Georg Schett Lehrstuhl für Innere Medizin III Jörg Distler Professur für Molekulare Mechanismen der Organfibrose

Involved external institutions

University College London (UCL) GB United Kingdom (GB) Universitätsspital Zürich (USZ) CH Switzerland (CH)

How to cite

APA:

Bergmann, C., Brandt, A., Dees, C., Wohlfahrt, T., Zhang, Y., Chen, C.-W.,... Distler, J. (2017). EPIGENETIC REGULATION OF FRA2 BY JMJD3 REGULATES FIBROBLAST ACTIVATION IN SYSTEMIC SCLEROSIS. (pp. 892-893).

MLA:

Bergmann, C., et al. "EPIGENETIC REGULATION OF FRA2 BY JMJD3 REGULATES FIBROBLAST ACTIVATION IN SYSTEMIC SCLEROSIS." 2017. 892-893.

BibTeX: Download